Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography

C.N.R. Institute of Clinical Physiology, Pisa, Italy.

To assess regional coronary reserve in hypertrophic cardiomyopathy, regional myocardial blood flow was measured in 23 patients with hypertrophic cardiomyopathy and 12 control subjects by means of nitrogen-13 ammonia and dynamic positron emission tomography. In patients with hypertrophic cardiomyopathy at baseline study, regional myocardial blood flow was 1.14 +/- 0.43 ml/min per g in the hypertrophied (20 +/- 3 mm) interventricular septum and 0.90 +/- 0.35 ml/min per g (p less than 0.05 versus septal flow) in the nonhypertrophied (10 +/- 2 mm) left ventricular free wall. These were not statistically different from the corresponding values in control subjects (1.04 +/- 0.25 and 0.91 +/- 0.21 ml/min per g, respectively, p = NS). After pharmacologically induced coronary vasodilation (dipyridamole, 0.56 mg/kg intravenously over 4 min), regional myocardial blood flow in patients with hypertrophic cardiomyopathy increased significantly less than in control subjects both in the septum (1.63 +/- 0.58 versus 2.99 +/- 1.06 ml/min per g, p less than 0.001) and in the free wall (1.47 +/- 0.58 versus 2.44 +/- 0.82 ml/min per g, p less than 0.001). In addition, patients with hypertrophic cardiomyopathy who had a history of chest pain had more pronounced impairment of coronary vasodilator reserve than did those without a history of chest pain. After dipyridamole, coronary resistance in the septum decreased by 38% in patients without a history of chest pain, but decreased by only 14% in those with such a history (p less than 0.05). Coronary resistance in the free wall decreased by 45% in patients without and by 27% in those with a history of chest pain (p = 0.06).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				B. J. Gersh, B. J. Maron, R. O. Bonow, J. A. Dearani, M. A. Fifer, M. S. Link, S. S. Naidu, R. A. Nishimura, S. R. Ommen, H. Rakowski, et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., December 13, 2011; 58(25): 2703 - 2738. [Full Text] [PDF]

				B. J. Gersh, B. J. Maron, R. O. Bonow, J. A. Dearani, M. A. Fifer, M. S. Link, S. S. Naidu, R. A. Nishimura, S. R. Ommen, H. Rakowski, et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., December 13, 2011; 58(25): e212 - e260. [Full Text] [PDF]

				Writing Committee Members, B. J. Gersh, B. J. Maron, R. O. Bonow, J. A. Dearani, M. A. Fifer, M. S. Link, S. S. Naidu, R. A. Nishimura, S. R. Ommen, et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation, December 13, 2011; 124(24): e783 - e831. [Full Text] [PDF]

				Writing Committee Members, B. J. Gersh, B. J. Maron, R. O. Bonow, J. A. Dearani, M. A. Fifer, M. S. Link, S. S. Naidu, R. A. Nishimura, S. R. Ommen, et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation, December 13, 2011; 124(24): 2761 - 2796. [Full Text] [PDF]

				Writing Committee Members:*, B. J. Gersh, B. J. Maron, R. O. Bonow, J. A. Dearani, M. A. Fifer, M. S. Link, S. S. Naidu, R. A. Nishimura, S. R. Ommen, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J. Thorac. Cardiovasc. Surg., December 1, 2011; 142(6): 1303 - 1338. [Full Text] [PDF]

				Writing Committee Members:*, B. J. Gersh, B. J. Maron, R. O. Bonow, J. A. Dearani, M. A. Fifer, M. S. Link, S. S. Naidu, R. A. Nishimura, S. R. Ommen, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J. Thorac. Cardiovasc. Surg., December 1, 2011; 142(6): e153 - e203. [Full Text] [PDF]

				S. A. J. Timmer, T. Germans, W. P. Brouwer, M. Lubberink, J. van der Velden, A. A. M. Wilde, I. Christiaans, A. A. Lammertsma, P. Knaapen, and A. C. van Rossum Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction Eur J Heart Fail, December 1, 2011; 13(12): 1283 - 1289. [Abstract] [Full Text] [PDF]

				K. Abozguia, P. Elliott, W. McKenna, T. T. Phan, G. Nallur-Shivu, I. Ahmed, A. R. Maher, K. Kaur, J. Taylor, A. Henning, et al. Metabolic Modulator Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy Circulation, October 19, 2010; 122(16): 1562 - 1569. [Abstract] [Full Text] [PDF]

				T. Tarumi, S. Takebayashi, M. Fujita, T. Nakano, M. Ito, and T. Yamakado Pacing tachycardia exaggerates left ventricular diastolic dysfunction but not systolic function and regional asynergy or asynchrony in patients with hypertrophic cardiomyopathy Europace, September 1, 2010; 12(9): 1308 - 1315. [Abstract] [Full Text] [PDF]

				E. J. Chun, S. I. Choi, K. N. Jin, H. J. Kwag, Y. J. Kim, B. W. Choi, W. Lee, and J. H. Park Hypertrophic Cardiomyopathy: Assessment with MR Imaging and Multidetector CT RadioGraphics, September 1, 2010; 30(5): 1309 - 1328. [Abstract] [Full Text] [PDF]

				M. S. Maron, I. Olivotto, B. J. Maron, S. K. Prasad, F. Cecchi, J. E. Udelson, and P. G. Camici The Case for Myocardial Ischemia in Hypertrophic Cardiomyopathy J. Am. Coll. Cardiol., August 25, 2009; 54(9): 866 - 875. [Abstract] [Full Text] [PDF]

				P. G. Camici and O. E. Rimoldi The Clinical Value of Myocardial Blood Flow Measurement J. Nucl. Med., July 1, 2009; 50(7): 1076 - 1087. [Abstract] [Full Text] [PDF]

				W A Jaber, E H Yang, R A Nishimura, P Sorajja, C S Rihal, A Elesber, E Eeckhout, and A Lerman Immediate improvement in coronary flow reserve after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy Heart, April 1, 2009; 95(7): 564 - 569. [Abstract] [Full Text] [PDF]

				P. G Camici Coronary Microvascular Dysfunction in Patients with Cardiomyopathies Circ Heart Fail, September 1, 2008; 1(3): 150 - 152. [Full Text] [PDF]

				B. Sotgia, R. Sciagra, I. Olivotto, G. Casolo, L. Rega, I. Betti, A. Pupi, P. G. Camici, and F. Cecchi Spatial Relationship Between Coronary Microvascular Dysfunction and Delayed Contrast Enhancement in Patients with Hypertrophic Cardiomyopathy J. Nucl. Med., July 1, 2008; 49(7): 1090 - 1096. [Abstract] [Full Text] [PDF]

				O. I I Soliman, P. Knaapen, M. L Geleijnse, P. A Dijkmans, A. M Anwar, A. Nemes, M. Michels, W. B Vletter, A. A Lammertsma, and F. J ten Cate Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography Heart, October 1, 2007; 93(10): 1204 - 1212. [Abstract] [Full Text] [PDF]

				S. E. Petersen, M. Jerosch-Herold, L. E. Hudsmith, M. D. Robson, J. M. Francis, H. A. Doll, J. B. Selvanayagam, S. Neubauer, and H. Watkins Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy: New Insights From Multiparametric Magnetic Resonance Imaging Circulation, May 8, 2007; 115(18): 2418 - 2425. [Abstract] [Full Text] [PDF]

				P. T. Siegrist, O. Gaemperli, P. Koepfli, T. Schepis, M. Namdar, I. Valenta, F. Aiello, S. Fleischmann, H. Alkadhi, and P. A. Kaufmann Repeatability of Cold Pressor Test-Induced Flow Increase Assessed with H215O and PET J. Nucl. Med., September 1, 2006; 47(9): 1420 - 1426. [Abstract] [Full Text] [PDF]

				T. O. Kiviniemi, A. Snapir, M. Saraste, J. O. Toikka, O. T. Raitakari, M. Ahotupa, J. J. Hartiala, M. Scheinin, and J. W. Koskenvuo Determinants of coronary flow velocity reserve in healthy young men Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H564 - H569. [Abstract] [Full Text] [PDF]

				I. Olivotto, F. Cecchi, R. Gistri, R. Lorenzoni, G. Chiriatti, F. Girolami, F. Torricelli, and P. G. Camici Relevance of Coronary Microvascular Flow Impairment to Long-Term Remodeling and Systolic Dysfunction in Hypertrophic Cardiomyopathy J. Am. Coll. Cardiol., March 7, 2006; 47(5): 1043 - 1048. [Abstract] [Full Text] [PDF]

				P M Elliott, H Kindler, J S Shah, B Sachdev, O E Rimoldi, R Thaman, M T Tome, W J McKenna, P Lee, and P G Camici Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with {alpha} galactosidase A Heart, March 1, 2006; 92(3): 357 - 360. [Abstract] [Full Text] [PDF]

				R. C. Brunken, J. K. Perloff, J. Czernin, R. Campisi, S. Purcell, P. D. Miner, J. S. Child, and H. R. Schelbert Myocardial perfusion reserve in adults with cyanotic congenital heart disease Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1798 - H1806. [Abstract] [Full Text] [PDF]

				P. A. Kaufmann and P. G. Camici Myocardial Blood Flow Measurement by PET: Technical Aspects and Clinical Applications J. Nucl. Med., January 1, 2005; 46(1): 75 - 88. [Full Text] [PDF]

				M. Jorg-Ciopor, M. Namdar, J. Turina, R. Jenni, J. Schwitter, M. Turina, O. M. Hess, and P. A. Kaufmann Regional myocardial ischemia in hypertrophic cardiomyopathy: Impact of myectomy J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 163 - 169. [Abstract] [Full Text] [PDF]

				R. Thaman, J. R. Gimeno, S. Reith, M. T. T. Esteban, G. Limongelli, R. T. Murphy, B. Mist, W. J. McKenna, and P. M. Elliott Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy J. Am. Coll. Cardiol., July 21, 2004; 44(2): 398 - 405. [Abstract] [Full Text] [PDF]

				S. Isobe, H. Izawa, Y. Takeichi, M. Nonokawa, M. Nanasato, A. Ando, K. Kato, M. Ikeda, T. Murohara, and M. Yokota Relationship Between Exercise-Induced Myocardial Ischemia and Reduced Left Ventricular Distensibility in Patients with Nonobstructive Hypertrophic Cardiomyopathy J. Nucl. Med., November 1, 2003; 44(11): 1717 - 1724. [Abstract] [Full Text] [PDF]

				H. Terai, M. Shimizu, H. Ino, M. Yamaguchi, K. Uchiyama, K. Oe, K. Nakajima, J. Taki, M. Kawano, and H. Mabuchi Changes in Cardiac Sympathetic Nerve Innervation and Activity in Pathophysiologic Transition from Typical to End-Stage Hypertrophic Cardiomyopathy J. Nucl. Med., October 1, 2003; 44(10): 1612 - 1617. [Abstract] [Full Text] [PDF]

				H. Izawa, M. Iwase, Y. Takeichi, F. Somura, K. Nagata, T. Nishizawa, A. Noda, T. Murohara, and M. Yokota Effect of Nicorandil on Left Ventricular End-Diastolic Pressure During Exercise in Patients with Hypertrophic Cardiomyopathy Eur. Heart J., July 2, 2003; 24(14): 1340 - 1348. [Abstract] [Full Text] [PDF]

				P. Sipola, K. Lauerma, M. Husso-Saastamoinen, J. T. Kuikka, E. Vanninen, T. Laitinen, H. Manninen, P. Niemi, K. Peuhkurinen, P. Jaaskelainen, et al. First-Pass MR Imaging in the Assessment of Perfusion Impairment in Patients with Hypertrophic Cardiomyopathy and the Asp175Asn Mutation of the {alpha}-Tropomyosin Gene Radiology, January 1, 2003; 226(1): 129 - 137. [Abstract] [Full Text] [PDF]

				B. J. Maron Hypertrophic Cardiomyopathy: A Systematic Review JAMA, March 13, 2002; 287(10): 1308 - 1320. [Abstract] [Full Text] [PDF]

				R. Jenni, C. A. Wyss, E. N. Oechslin, and P. A. Kaufmann Isolated ventricular noncompaction is associated with coronary microcirculatory dysfunction J. Am. Coll. Cardiol., February 6, 2002; 39(3): 450 - 454. [Abstract] [Full Text] [PDF]

				K. Rajappan, O. E. Rimoldi, D. P. Dutka, B. Ariff, D. J. Pennell, D. J. Sheridan, and P. G. Camici Mechanisms of Coronary Microcirculatory Dysfunction in Patients With Aortic Stenosis and Angiographically Normal Coronary Arteries Circulation, January 29, 2002; 105(4): 470 - 476. [Abstract] [Full Text] [PDF]

				E. Tadamura, H. Iida, K. Matsumoto, M. Mamede, S. Kubo, H. Toyoda, T. Shiozaki, T. Mukai, Y. Magata, and J. Konishi Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men J. Am. Coll. Cardiol., January 1, 2001; 37(1): 130 - 136. [Abstract] [Full Text] [PDF]

				D J R Hildick-Smith, P J Johnson, C R Wisbey, E M Winter, and L M Shapiro Coronary flow reserve is supranormal in endurance athletes: an adenosine transthoracic echocardiographic study Heart, October 1, 2000; 84(4): 383 - 389. [Abstract] [Full Text]

				H. Sakuma, J. W. Koskenvuo, P. Niemi, N. Kawada, J. O. Toikka, J. Knuuti, H. Laine, M. Saraste, M. Kormano, and J. J. Hartiala Assessment of Coronary Flow Reserve Using Fast Velocity-Encoded Cine MR Imaging: Validation Study Using Positron Emission Tomography Am. J. Roentgenol., October 1, 2000; 175(4): 1029 - 1033. [Abstract] [Full Text] [PDF]

				K. Okeie, M. Shimizu, H. Yoshio, H. Ino, M. Yamaguchi, T. Matsuyama, T. Yasuda, J. Taki, and H. Mabuchi Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy J. Am. Coll. Cardiol., September 1, 2000; 36(3): 856 - 863. [Abstract] [Full Text] [PDF]

				S.-T. Li, C. J. Tack, L. Fananapazir, and D. S. Goldstein Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1867 - 1873. [Abstract] [Full Text] [PDF]

				K. Kodama, Y. Shigematsu, M. Hamada, K. Hiwada, Y. Kazatani, K. Matsuzaki, and E. Murakami The Effect of Coronary Vasospasm on the Direction of ST-Segment Deviation in Patients With Both Hypertrophic Cardiomyopathy and Vasospastic Angina Chest, May 1, 2000; 117(5): 1300 - 1308. [Abstract] [Full Text] [PDF]

				O.-P. Pitkanen, P. Nuutila, O. T. Raitakari, K. Porkka, H. Iida, I. Nuotio, T. Ronnemaa, J. Viikari, M.-R. Taskinen, C. Ehnholm, et al. Coronary Flow Reserve in Young Men With Familial Combined Hyperlipidemia Circulation, April 6, 1999; 99(13): 1678 - 1684. [Abstract] [Full Text] [PDF]

				M. Krzanowski, A. Surdacki, R. Nizankowski, A. Szczeklik, J. S. Dubiel, and P. Petkow Dimitrow Impaired Response of the Forearm Resistance but not Conductance Vessels to Reactive Hyperemia in Hypertrophic Cardiomyopathy Angiology, April 1, 1999; 50(4): 267 - 272. [Abstract] [PDF]

				N. Kawada, H. Sakuma, T. Yamakado, K. Takeda, N. Isaka, T. Nakano, and C. B. Higgins Hypertrophic Cardiomyopathy: MR Measurement of Coronary Blood Flow and Vasodilator Flow Reserve in Patients and Healthy Subjects Radiology, April 1, 1999; 211(1): 129 - 135. [Abstract] [Full Text]

				M. Hamada, Y. Kazatani, K. Matsuzaki, E. Murakami, Y. Shigematsu, K. Hiwada, and K. Kodama Clinical Characteristics in Japanese Patients with Coexistent Hypertrophic Cardiomyopathy and Coronary Vasospasm Angiology, September 1, 1998; 49(9): 849 - 855. [Abstract] [PDF]

				T. Hirayama, K. Marumoto, H. Okayama, T. Iwata, and M. Suzuki Paroxysmal Atrial Fibrillation as a Cause of Potentially Lethal Ventricular Arrhythmia with Myocardial Ischemia in Hypertrophic Cardiomyopathy: A Case Report Angiology, August 1, 1998; 49(8): 653 - 657. [Abstract] [PDF]

				W.-I. Jung, L. Sieverding, J. Breuer, T. Hoess, S. Widmaier, O. Schmidt, M. Bunse, F. van Erckelens, J. Apitz, O. Lutz, et al. 31P NMR Spectroscopy Detects Metabolic Abnormalities in Asymptomatic Patients With Hypertrophic Cardiomyopathy Circulation, June 30, 1998; 97(25): 2536 - 2542. [Abstract] [Full Text] [PDF]

				I. Yokoyama, T. Ohtake, S.-i. Momomura, K. Yonekura, N. Kobayakawa, T. Aoyagi, S. Sugiura, Y. Sasaki, and M. Omata Altered Myocardial Vasodilatation in Patients With Hypertriglyceridemia in Anatomically Normal Coronary Arteries Arterioscler Thromb Vasc Biol, February 1, 1998; 18(2): 294 - 299. [Abstract] [Full Text] [PDF]

				R. Krams, M. J. M. Kofflard, D. J. Duncker, C. Von Birgelen, S. Carlier, M. Kliffen, F. J. t. Cate, and P. W. Serruys Decreased Coronary Flow Reserve in Hypertrophic Cardiomyopathy Is Related to Remodeling of the Coronary Microcirculation Circulation, January 27, 1998; 97(3): 230 - 233. [Abstract] [Full Text] [PDF]

				M. Schafers, D. Dutka, C. G. Rhodes, A. A. Lammertsma, F. Hermansen, O. Schober, and P. G. Camici Myocardial Presynaptic and Postsynaptic Autonomic Dysfunction in Hypertrophic Cardiomyopathy Circ. Res., January 23, 1998; 82(1): 57 - 62. [Abstract] [Full Text] [PDF]

				E. Lazzeroni, E. Picano, L. Morozzi, A. R. Maurizio, G. Palma, R. Ceriati, E. Iori, and A. Barilli Dipyridamole-Induced Ischemia as a Prognostic Marker of Future Adverse Cardiac Events in Adult Patients With Hypertrophic Cardiomyopathy Circulation, December 16, 1997; 96(12): 4268 - 4272. [Abstract] [Full Text]

				P. G. Camici, W. Wijns, M. Borgers, R. De Silva, R. Ferrari, J. Knuuti, A. A. Lammertsma, A. J. Liedtke, G. Paternostro, and S. F. Vatner Pathophysiological Mechanisms of Chronic Reversible Left Ventricular Dysfunction due to Coronary Artery Disease (Hibernating Myocardium) Circulation, November 4, 1997; 96(9): 3205 - 3214. [Full Text]

				M.G. Niemeyer, A.F.M. Kuijper, J.G. Meeder, M.J.M. Cramer, A.J.M. Cleophas, E.E. van der Wall, and M. G. Niemeyer Comparison of Thallium Scintigraphy and Positron Emission Tomography Angiology, October 1, 1997; 48(10): 843 - 853. [Abstract] [PDF]

				M. K. Gol, M. Emir, T. Keles, S. A. Kucuker, C. L. Birincioglu, Y. H. Karagoz, T. Kural, O. Tasdemir, S. Goksel, and K. Bayazit Septal Myectomy in Hypertrophic Obstructive Cardiomyopathy: Late Results With Stress Echocardiography Ann. Thorac. Surg., September 1, 1997; 64(3): 739 - 745. [Abstract] [Full Text]

				S. H. Rahimtoola Hibernating Myocardium Has Reduced Blood Flow at Rest That Increases With Low-Dose Dobutamine Circulation, December 15, 1996; 94(12): 3055 - 3061. [Full Text]

				I. Yokoyama, T. Ohtake, S.-i. Momomura, J. Nishikawa, Y. Sasaki, and M. Omata Reduced Coronary Flow Reserve in Hypercholesterolemic Patients Without Overt Coronary Stenosis Circulation, December 15, 1996; 94(12): 3232 - 3238. [Abstract] [Full Text]

				D. Annane, P. Merlet, H. Radvanyi, B. Mazoyer, B. Eymard, M. Fiorelli, C. Junien, M. Fardeau, Z. Ounnoughene, P. Gajdos, et al. Blunted Coronary Reserve in Myotonic Dystrophy An Early and Gene-Related Phenomenon: An Early and Gene-Related Phenomenon Circulation, September 1, 1996; 94(5): 973 - 977. [Abstract] [Full Text]

				D C Lefroy Grand Rounds - Hammersmith Hospital: Cardiac arrest and hypertrophic cardiomyopathy BMJ, November 12, 1994; 309(6964): 1277 - 1279. [Full Text]